Cargando…

The effects of time valuation in cancer optimal therapies: a study of chronic myeloid leukemia

BACKGROUND: The mathematical design of optimal therapies to fight cancer is an important research field in today’s Biomathematics and Biomedicine given its relevance to formulate patient-specific treatments. Until now, however, cancer optimal therapies have considered that malignancy exclusively dep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutiérrez-Diez, Pedro José, López-Marcos, Miguel Ángel, Martínez-Rodríguez, Julia, Russo, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540446/ https://www.ncbi.nlm.nih.gov/pubmed/31138288 http://dx.doi.org/10.1186/s12976-019-0106-4

Ejemplares similares

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
por: Russo, Domenico, et al.
Publicado: (2020)

The role of gene to gene interaction in the breast’s genomic signature of pregnancy
por: Gutiérrez-Díez, Pedro J., et al.
Publicado: (2021)

Optimized Treatment Schedules for Chronic Myeloid Leukemia
por: He, Qie, et al.
Publicado: (2016)

Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy
por: Carrà, Giovanna, et al.
Publicado: (2019)

Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission
por: Vigón, Lorena, et al.
Publicado: (2020)

Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
por: Swords, Ronan, et al.
Publicado: (2009)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023)

Valuation of Ecosystem Services Based on EU Carbon Allowances—Optimal Recovery for a Coal Mining Area
por: Krzemień, Alicja, et al.
Publicado: (2022)

Valuation
por: Kumar, Rajesh
Publicado: (2015)

Valuation
por: McKinsey & Company Inc, et al.
Publicado: (2020)

Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David, et al.
Publicado: (2007)

Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment
por: Stuckey, Ruth, et al.
Publicado: (2023)

Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia
por: Valencia, Ana, et al.
Publicado: (2009)

Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
por: Alarcón-Payer, Carolina, et al.
Publicado: (2022)

Reduced Hedonic Valuation of Rewards and Unaffected Cognitive Regulation in Chronic Stress
por: Ferreira, Sónia, et al.
Publicado: (2019)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Evaluation of Platelet-Rich Plasma by means of PRGF(®)-Endoret(®) protocol in leukemia cats: PDGF-BB and TGF-ß1 valuation
por: Miguel-Pastor, Laura, et al.
Publicado: (2023)

Valuation of Travel Time Savings in Viewpoint of WTA
por: Shao, Chang-qiao, et al.
Publicado: (2014)

Debating Frontline Therapy in Chronic Myeloid Leukemia
por: Bi, Xia, et al.
Publicado: (2021)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
por: Johnson-Ansah, Hyacinthe, et al.
Publicado: (2022)

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
por: García-Gutiérrez, Valentin, et al.
Publicado: (2022)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)

Chronic Myeloid Leukemia in India
por: Ganesan, Prasanth, et al.
Publicado: (2016)

Chronic Myeloid Leukemia in 2020
por: Hehlmann, Rüdiger
Publicado: (2020)

Chronic Myeloid Leukemia in 2007
por: Sessions, Jolynn
Publicado: (2007)

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
por: Calviño, Cristina, et al.
Publicado: (2023)

Drug Target Optimization in Chronic Myeloid Leukemia Using Innovative Computational Platform
por: Chuang, Ryan, et al.
Publicado: (2015)

Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David
Publicado: (2007)

Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Pulmonary leukostasis with severe respiratory impairment as a debut of acute myeloid leukemia
por: Rico-Rodríguez, José, et al.
Publicado: (2015)

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
por: Simoes, Catia, et al.
Publicado: (2022)

Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia
por: Momparler, Richard L
Publicado: (2013)

Corrigendum: Reduced Hedonic Valuation of Rewards and Unaffected Cognitive Regulation in Chronic Stress
por: Ferreira, Sónia, et al.
Publicado: (2019)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Cutaneous myeloid sarcoma associated with chronic myeloid leukemia
por: Vasconcelos, Erica Rodrigues de Araujo, et al.
Publicado: (2017)

Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tj7h1rhsp12oc2epkthovs475i